Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

University of Bern, Silence Therapeutics describe nucleic acids inhibiting PROS1

Nov. 30, 2020

Evrenzo approved in Japan for CKD anemia in adults not on dialysis

Nov. 27, 2020

Late events dog gene therapy

Nov. 24, 2020

Functional analysis complements sequencing

Nov. 17, 2020

FDA complete response letter for sutimlimab cites third-party manufacturing issues

Nov. 16, 2020

Rallybio begins phase I/II study of RLYB-211 for fetal and neonatal alloimmune thrombocytopenia

Nov. 11, 2020

Medshine Discovery synthesizes new factor XIa inhibitors

Nov. 6, 2020

Adakveo approved in Europe to prevent VOCs in patients with sickle cell disease

Nov. 4, 2020

A novel inducer of fetal hemoglobin with improved PK and PD properties

Nov. 3, 2020

INSERM and collaborators describe hematopoietic stem cells including beta globin gene

Nov. 2, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...